Table 2 Relationship between mean expression distance and clinical characteristics of patients with HCC.

Age

0.002^*

  Mean

62.85

59.59

55.86

  SD

10.78

13.46

15.15

Gender

0.004^*

  Male

97 (38.8%)

80 (32.0%)

73 (29.2%)

  Female

27 (22.3%)

43 (35.5%)

51 (42.1%)

Patient weight

p < 0.0001^**

  Mean

78.81

73.3

66.14

  SD

19.42

21.5

14.63

AFP

p < 0.0001^**

  <200 µg/L

91 (45.3%)

67 (33.3%)

43 (21.4%)

  ≥200 µg/L

7 (9.1%)

30 (39.0%)

40 (51.9%)

Child-Pugh grade

0.334

  a

84 (38.7%)

76 (35.0%)

57 (26.3%)

  b/c

5 (22.7%)

10 (45.5%)

7 (31.8%)

Tumor weight

p < 0.0001^**

  Mean

249.54

242.31

427.46

  SD

323.51

320.06

587.43

Vital status

0.006^*

  Alive

93 (38.6%)

79 (32.8%)

69 (28.6%)

  Dead

31 (23.8%)

44 (33.8%)

55 (42.3%)

Histological grade

p < 0.0001^**

  G1

24 (43.6%)

21 (38.2%)

10 (18.2%)

  G2

80 (45.2%)

51 (28.8%)

46 (26.0%)

  G3/4

19 (14.2%)

48 (35.8%)

67 (50%)

Pathological stage

p < 0.0001^**

  Stage I

76 (44.4%)

61 (35.7%)

34 (19.9%)

  Stage II

23 (26.7%)

27 (31.4%)

26 (28.9%)

  Stage III/IV

16 (17.8%)

26 (28.9%)

48 (53.3%)

T stage

p < 0.0001^**

  T1

81 (44.8%)

65 (35.9%)

35 (19.3%)

  T2

24 (25.5%)

30 (31.9%)

40 (42.6%)

  T3/4

17 (18.3%)

27 (29.0%)

49 (52.7%)

Inflammation

0.627

  No

50 (42.7%)

35 (29.9%)

32 (27.4%)

  Mild

35 (35.4%)

28 (28.3%)

36 (36.4%)

  Severe

7 (38.9%)

8 (44.4%)

3 (16.7%)

Vascular invasion

p < 0.0001^**

  No

86 (41.7%)

69 (33.5%)

51 (24.8%)

  Yes

24 (22.0%)

34 (31.2%)

51 (46.8%)